Description
ECZEMUS (Tacrolimus) 0.1% Ointment is indicated for short-term and intermittent long-term therapy in the treatment of moderate to severe atopic dermatitis (eczema) in adults.
Additional information
brand | Brookes Pharmaceutical Labs |
---|
brand | Brookes Pharmaceutical Labs |
---|